ImmunOs Therapeutics
Dr. Andreas Jurgeit is a Partner with the life science team of GIMV, a publicly listed (Euronext:GIMV) private equity and venture capital investor.
Previously, Andreas worked with the venture capital arm of Lundbeckfonden and at Merck Ventures where he was responsible for investments and company creation in Europe, the United States, and Israel. Andreas started his career at Redalpine Venture Partners and has operational experience in drug discovery, business development, and M&A.
This person is not in the org chart
This person is not in any teams
This person is not in any offices